Just some of this week’s social media excitement… saying no to ACS, what Open Access isn’t, considering cost in cancer care and more!
In an op-ed piece in the NY Times, three MSKCC doctors explained the decision to not include an expensive new treatment in the hospital formulary and encouraged others to consider cost as well as effectiveness when treating cancer patients. Many doctors were tweeting about the piece, and a short mention on the Washington Post’s Wonk Blog led to a number of comments (some very interesting). Over at FightColorectalCancer.org, there is a nice discussion of the piece and links to a number of responses around the web.
Another great post from Kevin Smith at Duke, clarifying What open access is not, and therefore touching on a number of important things about what it is, including the wide range of open access publishing models and the emerging field of Altmetrics.
SPARC has a story covering how one university is stepping away from a society publisher whose pricing model is unsustainable… SUNY Potsdam Takes Tough Stand Against American Chemistry Society Prices. Jenica Rodgers, librarian at SUNY Potsdam has blogged about the process as well.
The Washington Post reported that two major breast cancer charities have agreed to “best practices” to disclose information to consumers about what pink ribbon products benefit.